From Treon Verdery@21:1/5 to All on Wed Mar 1 04:16:13 2023
This study suggests that the rapamycin-polymer conjugate is a novel anti-cancer agent that may provide an attractive strategy for treatment of a wide variety of tumors.” hydrophilic rapamycin combined with regular rapamycin could reach a wider variety
of tissue types, combined they could cause greater than the 60% longevity increase published at mice
Optically activated rapamycin, “We developed an optically activated rapamycin dimer” perhaps a topical benefit
focusing rapamycin effect on just one tissue (kidney), “Thus subcapsular delivery of rapamycin-loaded microspheres successfully inhibited local fibrotic response in UUO with less systemic effects. Therapeutic effect of released rapamycin was most
prominent in close vicinity to the implanted microspheres.”